2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Elimination Disorders: new trials by email Literature Review of Elimination Disorders trials Research Report on Elimination Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE Mirabegron (beta3-adrenoceptor agonist), Anticholinergics, Desmopressin (DDAVP) - Nocturnal Enuresis in Children | Phase 3 | Recruiting | Mansoura University | 120 | 2024-12-01 | 2025-09-30 |
| Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry) Solifenacin, Mirabegron - Urinary Incontinence in Children | Phase 3 | Recruiting | University of Aarhus | 236 | 2024-06-27 | 2026-06-08 |
Diurnal Enuresis (1) · Nocturnal Enuresis (1) · Urinary Bladder, Overactive (1) · Urinary Incontinence (1)
Behavior (2) · Behavioral Symptoms (2) · Enuresis (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Mental Disorders (2) · Urination Disorders (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Lower Urinary Tract Symptoms (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Urinary Bladder Diseases (1)
mirabegron (2) · Cholinergic Antagonists (1) · Deamino Arginine Vasopressin (1) · Solifenacin Succinate (1)
Mansoura University (1) · University of Aarhus (1)
Denmark (1) · Egypt (1)